Veena S. John

1.2k total citations
26 papers, 268 citations indexed

About

Veena S. John is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Veena S. John has authored 26 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Reproductive Medicine and 6 papers in Molecular Biology. Recurrent topics in Veena S. John's work include Ovarian cancer diagnosis and treatment (15 papers), PARP inhibition in cancer therapy (8 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Veena S. John is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), PARP inhibition in cancer therapy (8 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Veena S. John collaborates with scholars based in United States, Malaysia and India. Veena S. John's co-authors include Daniel R. Budman, Karie Runcie, Nagashree Seetharamu, Myra F. Barginear, Stuart M. Lichtman, Sandeep H. Mashru, Anthony Calabro, Julia Tai, Jessica Lee and Andrew Menzin and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Veena S. John

20 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veena S. John United States 7 142 102 88 58 29 26 268
Leanne Lanieri United States 7 179 1.3× 86 0.8× 137 1.6× 33 0.6× 32 1.1× 17 286
Zhao Yang United States 10 199 1.4× 177 1.7× 73 0.8× 57 1.0× 67 2.3× 21 408
Luisa Sánchez‐Lorenzo Spain 7 190 1.3× 92 0.9× 62 0.7× 44 0.8× 67 2.3× 23 288
Ana T. Nunes United States 11 275 1.9× 120 1.2× 71 0.8× 81 1.4× 52 1.8× 19 455
Adela Poitevin Mexico 8 153 1.1× 94 0.9× 76 0.9× 27 0.5× 45 1.6× 11 406
Eric L. Powell United States 8 101 0.7× 87 0.9× 55 0.6× 17 0.3× 12 0.4× 13 213
Lieve Adriaens United States 7 164 1.2× 184 1.8× 66 0.8× 57 1.0× 5 0.2× 14 306
T Takahashi Japan 10 96 0.7× 145 1.4× 36 0.4× 51 0.9× 26 0.9× 30 350
Grete Hasvold Norway 9 101 0.7× 193 1.9× 69 0.8× 18 0.3× 10 0.3× 13 348
J Mansi United Kingdom 9 147 1.0× 108 1.1× 22 0.3× 25 0.4× 33 1.1× 18 328

Countries citing papers authored by Veena S. John

Since Specialization
Citations

This map shows the geographic impact of Veena S. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veena S. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veena S. John more than expected).

Fields of papers citing papers by Veena S. John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veena S. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veena S. John. The network helps show where Veena S. John may publish in the future.

Co-authorship network of co-authors of Veena S. John

This figure shows the co-authorship network connecting the top 25 collaborators of Veena S. John. A scholar is included among the top collaborators of Veena S. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veena S. John. Veena S. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lee, Amanda, et al.. (2024). Yolk sac tumor of the liver: Presentation, diagnosis, and treatment review.. Journal of Clinical Oncology. 42(16_suppl). e16371–e16371.
4.
Begum, Farhana, et al.. (2024). Hemolytic Anemia and Pancytopenia Secondary to Vitamin B12 Deficiency: Evaluation and Clinical Significance. Cureus. 16(3). e57286–e57286. 1 indexed citations
5.
Roychoudhury, Susanta, Karen S. King, Natarajan Aravindan, et al.. (2024). Cervical adenocarcinoma presenting as an ovarian torsion. Gynecologic Oncology Reports. 56. 101546–101546.
6.
Barbi, Mali, et al.. (2024). Navigating Hormone Therapy in Postmenopausal Women: Balancing Symptom Relief With Cancer Risk. Journal of Clinical Oncology. 42(30). 3517–3522. 1 indexed citations
7.
Disis, Mary L., Sarah F. Adams, Jyoti Bajpai, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006624–e006624. 14 indexed citations
8.
9.
Hernandez, Jennifer, et al.. (2022). A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients. Journal of Pharmacy Practice. 36(5). 1134–1141.
10.
Sakaris, Antoinette, et al.. (2021). Understanding the role of social media in caring for patients with gynecologic cancers. Gynecologic Oncology. 162. S321–S322.
11.
Goldberg, Gary L., Veena S. John, Douglas I. Lin, et al.. (2021). Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma. JCO Precision Oncology. 5(5). 1013–1023. 7 indexed citations
12.
John, Veena S., Nagashree Seetharamu, & Azzour D. Hazzan. (2020). Renal insufficiency in patients on PARP inhibitors: Case-based review of possible mechanisms and management. 5(1). 8–12.
13.
Frimer, Marina, et al.. (2020). The role of CCNE1 amplification in refractory ovarian and endometrial cancer. Gynecologic Oncology. 159. 216–216. 2 indexed citations
14.
Runcie, Karie, Daniel R. Budman, Veena S. John, & Nagashree Seetharamu. (2018). Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Molecular Medicine. 24(1). 50–50. 124 indexed citations
15.
Shapira, Iuliana, Lisa Rosen, Veena S. John, et al.. (2013). Correlation of in vitro chemotherapy drug resistance assay to clinical response to carboplatin and paclitaxel combination chemotherapy in ovarian carcinoma.. Journal of Clinical Oncology. 31(15_suppl). e16546–e16546. 2 indexed citations
16.
Barginear, Myra F., Veena S. John, & Daniel R. Budman. (2012). Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer. Molecular Medicine. 18(11). 1473–1479. 45 indexed citations
17.
Lovecchio, John L., et al.. (2011). Percutaneous Insertion of Peritoneal Ports. International Journal of Gynecological Cancer. 22(2). 328–331. 2 indexed citations
18.
Budman, Daniel R., Julia Tai, Anthony Calabro, & Veena S. John. (2010). The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines. Investigational New Drugs. 29(6). 1224–1229. 21 indexed citations
19.
Cannon, Mark, et al.. (2006). Prevention of mucositis in AutoBMT/stem cell transplant patients. Biology of Blood and Marrow Transplantation. 12(2). 100–101. 1 indexed citations
20.
John, Veena S., Sandeep H. Mashru, & Stuart M. Lichtman. (2003). Pharmacological Factors Influencing Anticancer Drug Selection in the Elderly. Drugs & Aging. 20(10). 737–759. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leanne Lanieri Breakdown of academic impact, for papers by Zhao Yang Breakdown of academic impact, for papers by Luisa Sánchez‐Lorenzo Breakdown of academic impact, for papers by Ana T. Nunes Breakdown of academic impact, for papers by Adela Poitevin Breakdown of academic impact, for papers by Eric L. Powell Breakdown of academic impact, for papers by Lieve Adriaens Breakdown of academic impact, for papers by T Takahashi Breakdown of academic impact, for papers by Grete Hasvold Breakdown of academic impact, for papers by J Mansi
Rankless by CCL
2026